Form 4: Anaptysbio Director Reports Stock Transaction
Insider Transaction (Form 4)
John A Orwin, a Director of Anaptysbio, Inc, reported multiple transactions in common stock on September 15, 2026.
Summary
- Option exercise/conversion: acquired 1,300 Common Stock on September 15, 2026; holds 17,995 after (Direct).
- Option exercise/conversion: disposed of 1,300 Restricted Stock Unit on September 15, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
John A Orwin — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-15 | Option exercise/conversion | Common Stock | 1,300 | — | — | 17,995 |
| 2026-09-15 | Option exercise/conversion | Restricted Stock Unit | 1,300 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-15 | Option exercise/conversion (1,300 shares) |
| 2026-09-15 | Option exercise/conversion (1,300 shares) |
Keywords
insider transaction, Form 4, ANAB, ANAPTYSBIO, INC, neutral, John A Orwin
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.